Cargando…

Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration

AIMS: Age-related macular degeneration (AMD) is a multifactorial disease, in which complement-mediated inflammation plays a pivotal role. A positive family history is an important risk factor for developing AMD. Certain lifestyle factors are shown to be significantly associated with AMD in non-famil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saksens, Nicole T. M., Lechanteur, Yara T. E., Verbakel, Sanne K., Groenewoud, Joannes M. M., Daha, Mohamed R., Schick, Tina, Fauser, Sascha, Boon, Camiel J. F., Hoyng, Carel B., den Hollander, Anneke I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892537/ https://www.ncbi.nlm.nih.gov/pubmed/27258093 http://dx.doi.org/10.1371/journal.pone.0144367

Ejemplares similares

A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo
por: Paun, Constantin C., et al.
Publicado: (2016)

Genetic Risk in Families with Age-Related Macular Degeneration
por: de Breuk, Anita, et al.
Publicado: (2021)

Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels
por: Ristau, Tina, et al.
Publicado: (2014)

Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
por: Smailhodzic, Dzenita, et al.
Publicado: (2014)

Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
por: Kersten, Eveline, et al.
Publicado: (2019)

Nutritional Risk Factors for Age-Related Macular Degeneration
por: Ersoy, Lebriz, et al.
Publicado: (2014)

Corrigendum to “Nutritional Risk Factors for Age-Related Macular Degeneration”
por: Ersoy, Lebriz, et al.
Publicado: (2016)

Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012)

Complement Activation Levels Are Related to Disease Stage in AMD
por: Heesterbeek, Thomas J., et al.
Publicado: (2020)

Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene
por: de Jong, Sarah, et al.
Publicado: (2021)

Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near MMP9
por: Lauwen, Susette, et al.
Publicado: (2021)

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages
por: Schick, Tina, et al.
Publicado: (2016)

Risk factors for progression of age‐related macular degeneration
por: Heesterbeek, Thomas J, et al.
Publicado: (2020)

Identification of TP53BP2 as a Novel Candidate Gene for Primary Open Angle Glaucoma by Whole Exome Sequencing in a Large Multiplex Family
por: Micheal, Shazia, et al.
Publicado: (2017)

Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration
por: Acar, I. Erkin, et al.
Publicado: (2021)

Evaluating the Occurrence of Rare Variants in the Complement Factor H Gene in Patients With Early-Onset Drusen Maculopathy
por: de Breuk, Anita, et al.
Publicado: (2021)

Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2015)

Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2016)

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016)

Alteration of retinal layers in healthy subjects over 60 years of age until nonagenarians
por: Altay, Lebriz, et al.
Publicado: (2017)

Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018)

Geographic distribution of rare variants associated with age-related macular degeneration
por: Geerlings, Maartje J., et al.
Publicado: (2018)

Analysis of hemopexin plasma levels in patients with age-related macular degeneration
por: Lauwen, Susette, et al.
Publicado: (2022)

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink, Myrte B, et al.
Publicado: (2016)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Analysis of Rare Variants in the C3 Gene in Patients with Age-Related Macular Degeneration
por: Duvvari, Maheswara R., et al.
Publicado: (2014)

Common and rare variants in patients with early onset drusen maculopathy
por: de Breuk, Anita, et al.
Publicado: (2022)

Genetic and environmental risk factors for extramacular drusen
por: Altay, Lebriz, et al.
Publicado: (2020)

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration
por: Kersten, Eveline, et al.
Publicado: (2018)

Family-based exome sequencing identifies rare coding variants in age-related macular degeneration
por: Ratnapriya, Rinki, et al.
Publicado: (2020)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age
por: Schick, Tina, et al.
Publicado: (2020)

Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration
por: Heesterbeek, Thomas J., et al.
Publicado: (2019)

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015)

Exome sequencing in patients with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome
por: Chung, Wing H, et al.
Publicado: (2016)

Association of plasma trace element levels with neovascular age-related macular degeneration
por: Heesterbeek, Thomas J., et al.
Publicado: (2020)

Systemic complement activation levels in Stargardt disease
por: Dhooge, Patty P. A., et al.
Publicado: (2021)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nae38q2693nl9lc2is5mqff5dd